These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 26006198)

  • 21. Rectal indomethacin with topical epinephrine versus indomethacin alone for preventing Post-ERCP pancreatitis - A systematic review and meta-analysis.
    Aziz M; Ghanim M; Sheikh T; Sharma S; Ghazaleh S; Fatima R; Khan Z; Lee-Smith W; Nawras A
    Pancreatology; 2020 Apr; 20(3):356-361. PubMed ID: 32107191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonsteroidal anti-inflammatory drugs reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.
    Li L; Han Z; Yuan H; Zhang G; Jia Y; He C
    J Hepatobiliary Pancreat Sci; 2017 Sep; 24(9):520-529. PubMed ID: 28681997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic Effect of Rectal Indomethacin Administration, with and without Intravenous Hydration, on Development of Endoscopic Retrograde Cholangiopancreatography Pancreatitis Episodes: A Randomized Clinical Trial.
    Hosseini M; Shalchiantabrizi P; Yektaroudy K; Dadgarmoghaddam M; Salari M
    Arch Iran Med; 2016 Aug; 19(8):538-43. PubMed ID: 27544361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials.
    Patai Á; Solymosi N; Mohácsi L; Patai ÁV
    Gastrointest Endosc; 2017 Jun; 85(6):1144-1156.e1. PubMed ID: 28167118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meta-analysis: rectal indomethacin for the prevention of post-ERCP pancreatitis.
    Yaghoobi M; Rolland S; Waschke KA; McNabb-Baltar J; Martel M; Bijarchi R; Szego P; Barkun AN
    Aliment Pharmacol Ther; 2013 Nov; 38(9):995-1001. PubMed ID: 24099466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of Post-ERCP Pancreatitis in Patients Receiving Rectal Indomethacin vs. Compounded Rectal Diclofenac Prophylaxis.
    Janssens LP; Yamparala A; Martin J; O'Meara J; Harmsen WS; Sathi T; Lemke E; Abu Dayyeh BK; Bofill-Garcia A; Petersen BT; Storm AC; Topazian M; Vargas EJ; Chandrasekhara V; Law RJ
    Dig Dis Sci; 2024 Oct; 69(10):3970-3978. PubMed ID: 39215866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indomethacin for post-endoscopic retrograde cholangiopancreatography pancreatitis prophylaxis: is it the magic bullet?
    Yang D; Draganov PV
    World J Gastroenterol; 2012 Aug; 18(31):4082-5. PubMed ID: 22919238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of rectal indomethacin for preventing post-ERCP pancreatitis depends on difficulties of cannulation: results from a randomized study with sequential biliary intubation.
    Patai Á; Solymosi N; Patai ÁV
    J Clin Gastroenterol; 2015; 49(5):429-37. PubMed ID: 25790233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indomethacin down-regulating HMGB1 and TNF-α to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
    Li L; Liu M; Zhang T; Jia Y; Zhang Y; Yuan H; Zhang G; He C
    Scand J Gastroenterol; 2019 Jun; 54(6):793-799. PubMed ID: 31177924
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of rectal indomethacin, diclofenac, and naproxen for the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
    Mohammad Alizadeh AH; Abbasinazari M; Hatami B; Abdi S; Ahmadpour F; Dabir S; Nematollahi A; Fatehi S; Pourhoseingholi MA
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):349-354. PubMed ID: 27849643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients.
    Levenick JM; Gordon SR; Fadden LL; Levy LC; Rockacy MJ; Hyder SM; Lacy BE; Bensen SP; Parr DD; Gardner TB
    Gastroenterology; 2016 Apr; 150(4):911-7; quiz e19. PubMed ID: 26775631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risk of post-ERCP pancreatitis and the protective effect of rectal indomethacin in cases of attempted but unsuccessful prophylactic pancreatic stent placement.
    Choksi NS; Fogel EL; Cote GA; Romagnuolo J; Elta GH; Scheiman JM; Chak A; Mosler P; Higgins PD; Korsnes SJ; Schmidt SE; Sherman S; Lehman GA; Elmunzer BJ;
    Gastrointest Endosc; 2015 Jan; 81(1):150-5. PubMed ID: 25527053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Incidence and Severity of Post-ERCP Pancreatitis in Patients Receiving Standard Administration of NSAIDs: a Systematic Review and Meta-analysis.
    Kang X; Guo X; Chen Z; Zhou Z; Luo H; Lu Y; Lou L; Guo X; Pan Y
    J Gastrointest Surg; 2022 Nov; 26(11):2380-2389. PubMed ID: 35941494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis.
    Akshintala VS; Sperna Weiland CJ; Bhullar FA; Kamal A; Kanthasamy K; Kuo A; Tomasetti C; Gurakar M; Drenth JPH; Yadav D; Elmunzer BJ; Reddy DN; Goenka MK; Kochhar R; Kalloo AN; Khashab MA; van Geenen EJM; Singh VK
    Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):733-742. PubMed ID: 34214449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Bai Y; Xu C; Yang X; Gao J; Zou DW; Li ZS
    Endoscopy; 2009 Aug; 41(8):690-5. PubMed ID: 19670137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with a combination of pharmacological agents based on rectal non-steroidal anti-inflammatory drugs: A systematic review and network meta-analysis.
    Oh HC; Kang H; Park TY; Choi GJ; Lehman GA
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1403-1413. PubMed ID: 33068012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic corticosteroids do not prevent post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
    Bai Y; Gao J; Shi X; Zou D; Li Z
    Pancreatology; 2008; 8(4-5):504-9. PubMed ID: 18765955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rectal Nonsteroidal Anti-Inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: A Network Meta-Analysis.
    Yang J; Wang W; Liu C; Zhao Y; Ren M; He S
    J Clin Gastroenterol; 2020 Apr; 54(4):305-313. PubMed ID: 32011404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-ERCP pancreatitis.
    Arata S; Takada T; Hirata K; Yoshida M; Mayumi T; Hirota M; Yokoe M; Hirota M; Kiriyama S; Sekimoto M; Amano H; Wada K; Kimura Y; Gabata T; Takeda K; Kataoka K; Ito T; Tanaka M
    J Hepatobiliary Pancreat Sci; 2010 Jan; 17(1):70-8. PubMed ID: 20012323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk Factors for Post-ERCP Pancreatitis in High-Risk Patients Receiving Post-procedure Rectal Indomethacin.
    Kang X; Zheng L; Zeng W; Yang S; Sun H; Zhang R; Wang X; Wang B; Tao Q; Yao S; Chen J; Pan Y; Guo X
    J Gastrointest Surg; 2018 Nov; 22(11):1903-1910. PubMed ID: 29980976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.